Historical Stock Price
ETFs Holding ACAD »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
04/14/2021 $20.61 $21.78 $20.61 $21.28 2.84M
04/15/2021 $21.34 $21.57 $21.03 $21.20 2.22M
04/16/2021 $21.32 $21.40 $20.84 $21.15 4.78M
04/19/2021 $21.04 $21.42 $20.24 $20.72 2.26M
04/20/2021 $20.70 $21.25 $20.59 $20.80 1.47M
Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines focusing on central nervous system disorders. Co. has a portfolio of product including its drug, NUPLAZID (pimavanserin), which has been approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PD Psychosis). NUPLAZID is a selective serotonin inverse agonist preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors.
ACAD historical stock prices picture
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on April 14, 2021, ACAD opened at $20.61, traded as high as $21.78 and as low as $20.61, and closed at $21.28. Trading volume was a total of 2.84M shares. On April 15, 2021, ACAD opened at $21.34, traded as high as $21.57 and as low as $21.03, and closed at $21.20. Trading volume was a total of 2.22M shares. On April 16, 2021, ACAD opened at $21.32, traded as high as $21.40 and as low as $20.84, and closed at $21.15. Trading volume was a total of 4.78M shares. On April 19, 2021, ACAD opened at $21.04, traded as high as $21.42 and as low as $20.24, and closed at $20.72. Trading volume was a total of 2.26M shares. On April 20, 2021, ACAD opened at $20.70, traded as high as $21.25 and as low as $20.59, and closed at $20.80. Trading volume was a total of 1.47M shares.

ACAD Historical Stock Prices By Date:

ACAD historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/21/2011
End date: 04/20/2021
Start price/share: $2.24
End price/share: $20.80
Dividends collected/share: $0.00
Total return: 828.57%
Average Annual Total Return: 24.95%
Starting investment: $10,000.00
Ending investment: $92,873.68
Years: 10.01
Date Close
04/14/2021$21.28
04/15/2021$21.20
04/16/2021$21.15
04/19/2021$20.72
04/20/2021$20.80
ACAD is categorized under the Healthcare sector; below are some other companies in the same sector:

ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices
ACOR Historical Stock Prices
ACRS Historical Stock Prices
ACRX Historical Stock Prices
ACST Historical Stock Prices
ACT Historical Stock Prices

Also explore: ACAD shares outstanding history

ACAD Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.